Product image of Lemod Solu (Methylprednisolone) supplied by GNH India

Lemod Solu

Active Ingredient:
Methylprednisolone
Origin:
EU

Lemod Solu (Methylprednisolone)

Methylprednisolone, the active ingredient in Lemod Solu, is a corticosteroid presented as a sterile solution for intramuscular and intravenous use. It reduces inflammation and suppresses immune responses, and is employed in severe allergic reactions, asthma exacerbations, rheumatic disorders, dermatologic inflammation, and as an immunosuppressant in organ transplantation.

GNH India supplies Lemod Solu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide, ensuring quality, regulatory compliance and reliable logistics for injectable medicines through a robust distribution network.

Manufacturer / TM Owner

Stada Hemofarm S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methylprednisolone acts on inflammatory and immune pathways to treat several acute and chronic conditions.

  • Severe allergic reactions: rapid reduction of airway swelling and systemic inflammation.
  • Asthma exacerbations: prompt reversal of bronchospasm and airway inflammation.
  • Rheumatic and musculoskeletal disorders: alleviation of joint pain, swelling and stiffness.
  • Dermatologic inflammatory conditions: control of severe skin inflammation such as eczema or psoriasis flares.
  • Organ transplantation: prevention of acute rejection by suppressing immune activation.

How It Works

  • Methylprednisolone diffuses across cell membranes and binds to intracellular glucocorticoid receptors. The receptor complex translocates to the nucleus, where it binds glucocorticoid response elements and modulates transcription of anti‑inflammatory proteins while repressing pro‑inflammatory cytokine genes. This results in decreased leukocyte migration, reduced capillary permeability, and inhibition of immune cell activation. Additionally, it down‑regulates expression of adhesion molecules and stabilizes lysosomal membranes, further limiting tissue damage.

Side Effects

Methylprednisolone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Increased blood glucose: transient hyperglycemia, especially in diabetic patients.
  • Fluid retention: mild edema or weight gain.
  • Mood changes: irritability, anxiety or insomnia.
  • Gastrointestinal discomfort: nausea or abdominal pain.

Serious or Rare Side Effects

  • Severe infection: heightened risk of bacterial, viral or fungal infections.
  • Adrenal suppression: potential for cortisol deficiency on abrupt discontinuation.
  • Osteonecrosis: rare bone tissue death, particularly with high‑dose or prolonged therapy.

Precautions & Warnings

Before using Lemod Solu, consider the following precautions to minimize risks.

  • Assess infection risk: avoid use in active uncontrolled infections.
  • Monitor glucose: check blood sugar in diabetic or predisposed patients.
  • Evaluate bone health: limit long‑term use in patients with osteoporosis.
  • Screen for psychiatric history: watch for mood or psychotic symptoms.
  • Adjust dose in hepatic impairment: use the lowest effective amount.
  • Store at ambient temperature: keep below 25 °C, protect from light and moisture in original container.

Avoid Interactions

Methylprednisolone can interact with several medicines; awareness of major and moderate interactions helps ensure safe therapy.

Major Interactions (Avoid)

  • CYP3A4 inhibitors: may increase steroid levels and toxicity (e.g., ketoconazole).
  • Live vaccines: risk of severe infection due to immunosuppression.
  • Anticoagulants: enhanced anticoagulant effect, increasing bleeding risk.
  • NSAIDs: heightened risk of gastrointestinal ulceration and bleeding.

Moderate Interactions (Monitor Closely)

  • Diuretics: may potentiate hypokalemia.
  • Antidiabetic drugs: may require dose adjustments for hyperglycemia.
  • Antihypertensives: possible reduction in blood pressure control.

Frequently Asked Questions

Lemod Solu contains methylprednisolone, a glucocorticoid used to treat severe allergic reactions, asthma exacerbations, rheumatic and musculoskeletal disorders, dermatologic inflammatory conditions, and to provide immunosuppression in organ‑transplant patients.

Methylprednisolone binds to intracellular glucocorticoid receptors, altering gene transcription. This suppresses pro‑inflammatory cytokines, reduces leukocyte migration, and stabilises cell membranes, leading to decreased inflammation and immune activity.

The dose of Lemod Solu is individualized by the prescribing clinician based on the specific indication, severity of disease, patient weight, and response. Exact dosing regimens are not provided here.

Methylprednisolone is classified as pregnancy category unknown. Use during pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or infant, and after careful evaluation by a healthcare professional.

To order Lemod Solu, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lemod Solu delivers methylprednisolone, which has a higher anti‑inflammatory potency than prednisone and a shorter biological half‑life than dexamethasone. This profile can allow rapid control of severe inflammation with potentially fewer long‑term side effects when used appropriately.

Store Lemod Solu at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from light and moisture, and avoid freezing. Follow standard aseptic techniques when preparing for intramuscular or intravenous administration.

Lemod Solu is supplied as a sterile injectable solution for intramuscular or intravenous injection. Administration is performed by a qualified healthcare professional using aseptic technique, with the dose and route selected according to the clinical indication.

Serious risks include severe infections due to immunosuppression, adrenal insufficiency on abrupt discontinuation, and rare complications such as osteonecrosis. Patients should be monitored for signs of infection, abnormal fatigue, joint pain, or unexplained bruising.

Lemod Solu is contraindicated in patients with known hypersensitivity to methylprednisolone or any component of the formulation, and in those with active, uncontrolled systemic infections. Caution is also advised for individuals with uncontrolled diabetes, severe osteoporosis, or psychiatric disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT